Biology Reference
In-Depth Information
Filgueiras CC, Krahe TE, Medina AE (2010) Phosphodiesterase type 1 inhibition improves
learning in rats exposed to alcohol during the third trimester equivalent of human gestation.
Neurosci Lett 473:202-207
Fink HA, Mac Donald R, Rutks IR, Nelson DB, Wilt TJ (2002) Sildenafil for male erectile
dysfunction: a systematic review and meta-analysis. Arch Intern Med 162:1349-1360
Francis SH (2005) Phosphodiesterase 11 (PDE11): is it a player in human testicular function?
Int J Impot Res 17:467-468
Francis SH, Lincoln TM, Corbin JD (1980) Characterization of a novel cGMP binding protein
from rat lung. J Biol Chem 255:620-626
Francis SH, Busch JL, Corbin JD (2010) cGMP-dependent protein kinases and cGMP phospho-
diesterases in nitric oxide and cGMP action. Pharmacol Rev 62:525-563
Frey U, Huang Y, Kandel ER (1993) Effects of cAMP simulate a late stage of LTP in hippocampal
CA1 neurons. Science 260:1661-1664
Fujioka T, Fujioka A, Duman RS (2004) Activation of cAMP signaling facilitates themorpholo-
gical maturation of newborn neurons in adult hippocampus. J Neurosci 24:319-328
Fujishige K, Kotera J, Omori K (1999) Striatum- and testis-specific phosphodiesterase PDE10A
isolation and characterization of a rat PDE 10A. Eur J Biochem 266:1118-1127
Gao Y, Deng K, Hou J, Bryson JB, Barco A, Nikulina E, Spencer T, Mellado W, Kandel ER,
Filbin MT (2004) Activated CREB is sufficient to overcome inhibitors in myelin and promote
spinal axon regeneration in vivo. Neuron 44:609-621
Garthwaite J, Boulton CL (1995) Nitric oxide signaling in the central nervous system. Annu Rev
Physiol 57:683-706
Gong B, Vitolo OV, Trinchese F, Liu S, Shelanski M, Arancio O (2004) Persistent improvement
in synaptic and cognitive functions in an Alzheimer mouse model after rolipram treatment.
J Clin Invest 114:1624-1634
Gross-Langenhoff M, Hofbauer K, Weber J, Schultz A, Schultz JE (2006) camp is a ligand for the
tandem GAF domain of human phosphodiesterase 10 and cGMP for the tandem GAF domain
of phosphodiesterase 11. J Biol Chem 281:2841-2846
Guo J, Watson A, Kempson J, Carlsen M, Barbosa J, Stebbins K, Lee D, Dodd J, Nadler SG,
McKinnon M, Barrish J, Pitts WJ (2009) Identification of potent pyrimidine inhibitors of
phosphodiesterase 7 (PDE7) and their ability to inhibit T cell proliferation. Bioorg Med Chem
Lett 19:1935-1938
Hajjhussein H, Suvarna NU, Gremillion C, Chandler LJ, O'Donnell JM (2007) Changes in NMDA
receptor-induced cyclic nucleotide synthesis regulated the age-dependent increase in PDE4A
expression in primary cortical cultures. Brain Res 1149:58-68
Haley JE, Malen PL, Chapman PF (1993) Nitric oxide synthase inhibitors block long term
potentiation induced by weak but not strong tetanic stimulation at physiological brain tem-
peratures in rat hippocampal slices. Neurosci Lett 160:85-88
Han P, Zhu XY, Michaeli T (1997) Alternative splicing of the high affinity cAMP-specific
phosphodiesterase (PDE7A) mRNA in human skeletal muscle and heart. J Biol Chem 272:
16152-16157
Han P, Werber J, Surana M, Fleischer N, Michaeli T (1999) The calcium/calmodulin-dependent
phosphodiesterase PDE1C down-regulates glucose-induced insulin secretion. J Biol Chem
274:22337-22344
Hartell NA (1996) Inhibition of cGMP breakdown promotes the induction of cerebellar long-term
depression. J Neurosci 16:2881-2890
Hebb ALO, Robertson HA, Denovan-Wright EM (2004) Striatal phosphodiesterase mRNA and
protein levels are reduced in Huntington's Disease transgenic mice prior to the onset of motor
symptoms. Neuroscience 123:967-981
Hebb AL, Robertson HA, Denovan-Wright EM (2008) Phosphodiesterase 10A inhibition is
associated with locomotor and cognitive deficits and increased anxiety in mice. Eur Neurop-
sychopharmacol 18:339-363
